Experimental coronavirus drug remdesivir is showing an early promise
Experimental coronavirus drug remdesivir is showing early promise
The experimental COVID-19 treatment remdesivir is showing early promise in the battle against the coronavirus outbreak, according to a small research study.
The study, which was published in the New England Journal of Medicine, was supported by remdesivir developer Gilead Sciences.
“These are patients who received treatment through the compassionate use program for remdesivir, which is for critically ill patients who are unable to take part in a clinical trial,” said Gilead CEO Daniel O’Day in an open letter released Friday. “The results, which cover 53 of the first patients to have been treated in the program, show that the majority demonstrated clinical improvement after taking remedesivir.”
-
3:00
BPR
4 years agoCoronavirus survivor says experimental drug saved husband's life
6.96K -
2:44
WPTV
4 years agoNew coronavirus treatment showing promise in Palm Beach Gardens
9 -
2:36
Newsy
4 years agoU.S. Official 'Hopeful' Experimental Drug Could Treat Coronavirus
244 -
1:23
WFTX
4 years agoPotential coronavirus vaccine shows promise
1.8K -
0:25
WFTX
4 years agoFDA allows emergency use of experimental drug for coronavirus treatment
16 -
0:50
Newsy
4 years agoReport: Coronavirus Drug Trials May Show Promise But More Tests Needed
498 -
1:53
BPR
4 years agoTrump predicts coronavirus vaccine as early as December
2.55K1 -
2:11
KGUN
4 years agoDoctor graduates early to battle coronavirus
8 -
2:55
KMGH
4 years agoUCHealth part of remdesivir clinical trial to determine how long experimental drug should be used
11 -
2:44
KJRH
5 years agoGenetic research showing promise in fighting ovarian cancer
21